These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7317971)

  • 21. Intraocular irrigating solutions: the importance of Ca++ and glass versus polypropylene bottles.
    Watsky MA; Edelhauser HF
    Int Ophthalmol Clin; 1993; 33(4):109-25. PubMed ID: 8258491
    [No Abstract]   [Full Text] [Related]  

  • 22. Streptokinase flocculation in evacuated glass bottles.
    Thibault L
    Am J Hosp Pharm; 1985 Feb; 42(2):278, 280. PubMed ID: 3976669
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
    Lebitasy M; Hecq JD; Athanassopoulos A; Vanbeckbergen D; Jamart J; Galanti L
    J Clin Pharm Ther; 2009 Aug; 34(4):423-8. PubMed ID: 19583675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3. Plastics for packaging ophthalmic preparations.
    Mullins JD
    Bull Parenter Drug Assoc; 1968; 22(1):38-41. PubMed ID: 5636760
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modern concepts of preparation of ophthalmic solutions].
    Bagnarelli AE
    Rev Sanid Milit Argent; 1967; 66(2):205-10. PubMed ID: 5613557
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and manufacture of ophthalmic products.
    Mullins JD
    Bull Parenter Drug Assoc; 1966; 20(2):48-55. PubMed ID: 5905228
    [No Abstract]   [Full Text] [Related]  

  • 27. [Stability of aqueous solutions of aureomycin hydrochloride in the presence of some substances applied in ophthalmic drops].
    Olszewski Z; Grabowska-Bochenek J
    Acta Pol Pharm; 1967; 24(5):505-9. PubMed ID: 6062758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prescriptions of ophthalmic solutions].
    Pöppel P
    Pharm Prax; 1970; 2():31-5. PubMed ID: 5517092
    [No Abstract]   [Full Text] [Related]  

  • 29. [On problems in the preparation of ophthalmic solutions following DAB 7 with 2 or more drugs].
    Brockelt G
    Pharm Prax; 1966; 6():135-7. PubMed ID: 5960337
    [No Abstract]   [Full Text] [Related]  

  • 30. Good manufacturing practice for single dose ophthalmic products.
    Hall NC
    Bull Parenter Drug Assoc; 1972; 26(4):193-7. PubMed ID: 5041145
    [No Abstract]   [Full Text] [Related]  

  • 31. [The influence of polivinyl chloride containers (PCW) on the quality of 5% glucose solution for injections. Part II (author's transl)].
    Krasowska M
    Ann Univ Mariae Curie Sklodowska Med; 1976; 31():181-5. PubMed ID: 1032777
    [No Abstract]   [Full Text] [Related]  

  • 32. [Of an ophthalmic solution based on cystein (author's transl)].
    Bovis A; Reynier JP; Estachy G; Saracco J
    J Pharm Belg; 1978; 33(4):247-50. PubMed ID: 712543
    [No Abstract]   [Full Text] [Related]  

  • 33. Elimination of particulate contamination from ophthalmic solutions for intraocular surgery.
    Jaffe NS
    Bull Parenter Drug Assoc; 1970; 24(5):218-25. PubMed ID: 5471332
    [No Abstract]   [Full Text] [Related]  

  • 34. A wide pH range stopper for improved particulate quality in parenteral solutions.
    Knapp JZ; Dull HF; Bjorndal PM; Brakl SF; Yuen PC
    J Parenter Sci Technol; 1984; 38(4):128-38. PubMed ID: 6491855
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comments and control studies on the size of drug particles contained in ophthalmic ointments].
    Doden W; Faulborn J
    Klin Monbl Augenheilkd; 1967; 150(5):727-32. PubMed ID: 5586134
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteriological control of collyria.
    Papavassiliou J; Albalas B; Zouroudis N; Chitiroglou-Lada K; Siouti M
    Pharm Acta Helv; 1977; 52(12):293-5. PubMed ID: 615315
    [No Abstract]   [Full Text] [Related]  

  • 37. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservative combinations: a microbiological assessment.
    Wakely JH; Hall NC; Krezanoski JZ
    Bull Parenter Drug Assoc; 1967; 21(4):124-35. PubMed ID: 6045458
    [No Abstract]   [Full Text] [Related]  

  • 39. Ophthalmic medications and pharmacology.
    Duvall B; Kershner RM
    J Ophthalmic Nurs Technol; 1998; 17(4):151-8. PubMed ID: 9883136
    [No Abstract]   [Full Text] [Related]  

  • 40. Can your hypochlorite solutions withstand the test of time?
    Todays Surg Nurse; 1998; 20(4):38-41. PubMed ID: 10026645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.